Zobrazeno 1 - 10
of 20
pro vyhledávání: '"David L Krah"'
Autor:
Katherine S Lee, Wenbo Zhou, Jonah J Scott-McKean, Kaitlin L Emmerling, Guang-yun Cai, David L Krah, Alberto C Costa, Curt R Freed, Myron J Levin
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e53010 (2012)
After primary infection, varicella-zoster virus (VZV) establishes latency in neurons of the dorsal root and trigeminal ganglia. Many questions concerning the mechanism of VZV pathogenesis remain unanswered, due in part to the strict host tropism and
Externí odkaz:
https://doaj.org/article/bbb1b85dc5c949af849f869d36b9dc3f
Autor:
Andreas Wieland, Nadine Rouphael, Megan McCausland, Eberhard Durr, Bali Pulendran, Rafi Ahmed, Kalpit A. Vora, Nicole L. Sullivan, David L. Krah, Carl W. Davis, Aneesh K. Mehta, Janet J. Sei, Morgan A. Reuter-Monslow, Cathy Y. Chang, Mark J. Mulligan
Herpes zoster (HZ) (shingles) is the clinical manifestation of varicella-zoster virus (VZV) reactivation. HZ typically develops as people age, due to decreased cell-mediated immunity. However, the importance of antibodies for immunity against HZ prev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bafe72decd48eb9f09e48ced0c41819a
https://europepmc.org/articles/PMC6026762/
https://europepmc.org/articles/PMC6026762/
Autor:
Kara S. Cox, Janet J. Sei, Kalpit A. Vora, Sheri Dubey, Danilo R. Casimiro, Joseph M. Antonello, David L. Krah
Publikováno v:
Frontiers in Immunology
ZOSTAVAX(®) is a live attenuated varicella-zoster virus (VZV) vaccine that is licensed for the protection of individuals ≥50 years against shingles and its most common complication, postherpetic neuralgia. While IFNγ responses increase upon vacci
Autor:
Paul A. Offit, Penny Heaton, Karen M. Kaplan, H Fred Clark, Digilio Laura, Penelope H. Dennehy, Michael J. Dallas, Michael E. Pichichero, Alan Shaw, Richard L. Ward, David L. Krah, Joseph J. Eiden, David I. Bernstein, John J. Treanor, Nathalie Ivanoff
Publikováno v:
The Journal of Pediatrics. 144:184-190
Objectives To investigate safety, efficacy, and immunogenicity of live quadrivalent rotavirus vaccine (QRV) containing human-bovine (WC3) reassortant rotavirus serotypes G1, G2, G3, and P1a. Study design This was a randomized, double-blinded, placebo
Autor:
Jan ter Meulen, Jesse Dewane, Christine Meyer, Ilhem Messaoudi, Nicole Arnold, David L. Krah, Kristen Haberthur, Flora Engelmann
Varicella-zoster virus (VZV) is a human neurotropic alphaherpesvirus and the etiological agent of varicella (chickenpox) and herpes zoster (HZ, shingles). Previously, inoculation of monkeys via the subcutaneous, intratracheal, intravenous, or oral-na
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35045bf11dcfc385088f86ab454e08d3
https://europepmc.org/articles/PMC4300754/
https://europepmc.org/articles/PMC4300754/
Autor:
Michael E. Pichichero, Paul A. Offit, F. E. Borian, R. W. Ellis, Alan Shaw, David L. Krah, H. F. Clark, John J. Treanor, Stanley A. Plotkin, Louis M. Bell, Joseph J. Eiden
Publikováno v:
Journal of Infectious Diseases. 174:S73-S80
Laboratory and clinical studies have been directed toward development of a vaccine against rotavirus gastroenteritis in infants. First, bovine rotavirus strain WC3, which did not induce neutralizing antibodies to predominant human rotavirus (HRV) ser
Autor:
Myron J. Levin, Jonah J. Scott-McKean, Curt R. Freed, Alberto C.S. Costa, David L. Krah, Katherine S. Lee, Kaitlin L. Emmerling, Guang-Yun Cai, Wenbo Zhou
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 12, p e53010 (2012)
PLoS ONE, Vol 7, Iss 12, p e53010 (2012)
After primary infection, varicella-zoster virus (VZV) establishes latency in neurons of the dorsal root and trigeminal ganglia. Many questions concerning the mechanism of VZV pathogenesis remain unanswered, due in part to the strict host tropism and
Autor:
David L. Krah
Publikováno v:
Microbial Pathogenesis. 11:221-228
Autor:
Penny Heaton, Paul A. Offit, Karen M. Kaplan, David L. Krah, W Manfred Gooch, Florian Schödel, Carl J. Burke, Penelope H. Dennehy, Michael J. Dallas, Joseph S. Bresee, H Fred Clark, David O. Matson, Emmanuel B. Walter, Edgardo A. Malacaman, Richard L. Ward, Barbara Watson, David B. Volkin
Publikováno v:
The Pediatric infectious disease journal. 22(10)
A refrigerator-stable rotavirus (RV) vaccine that withstands gastric acid is anticipated to permit more widespread use of RV vaccine.We investigated for the first time in infants an oral, liquid formulation of G1 and G2 human bovine reassortant rotav
Autor:
David L. Krah
Publikováno v:
Biologicals : journal of the International Association of Biological Standardization. 19(3)
A standardized multiwell plate assay (MWPA) was developed to provide a simple in situ measurement of hepatitis A virus (HAV) infectivity titers. Following attachment (4 h, 35 degrees C) of serial 10-fold dilutions of HAV strain CR326 F (variant F') t